| 1 |
33976256 | IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen. | 2021 May 11 |
1 |
| 2 |
30266764 | Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas. | 2019 Jan 15 |
1 |
| 3 |
29453678 | Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas. | 2018 Jun |
3 |
| 4 |
27116977 | IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. | 2016 Oct |
4 |
| 5 |
24936872 | Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis. | 2014 |
1 |
| 6 |
24077826 | Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine. | 2013 Oct |
4 |